Drug Type Autologous CAR-T |
Synonyms- |
Target |
Mechanism CD123 modulators(Interleukin-3 receptor subunit alpha modulators), TIM3 modulators(Hepatitis A virus cellular receptor 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Phase 2 | CN | 04 Nov 2023 |